Path2 Hydrogen AG: management transactions · Germany · BaFin

About Path2 Hydrogen AG

Path2 Hydrogen AG is a German-listed company traded on Xetra/Frankfurt (DAX/MDAX/SDAX) under ticker PTHH.DE and ISIN DE000A1A6WB2. The equity story is centered on hydrogen infrastructure, and in 2025 the company became much more clearly defined after completing the acquisition of GenH2 Corp. Path2 Hydrogen now presents itself as a publicly traded holding and development platform focused on building an integrated hydrogen value chain: liquefaction, transfer, storage and dispensing of liquid hydrogen. For investors, the key point is that this is less a mature utility-like business than a strategic hydrogen platform with meaningful execution and commercialization optionality. ([path2hydrogen.com](https://path2hydrogen.com/about-us/)) The company is based in Munich, Germany, with its corporate address at Marienplatz 2, 80331 Munich, while Path2 Hydrogen’s website also lists Berlin contact details for investor and corporate communication. The 2025 listing documentation and interim report show that the issuer previously operated as Philomaxcap AG before the name change to Path2 Hydrogen AG. The same filings also indicate that the group has a long corporate history going back to the late 1990s, but its current hydrogen-focused identity is recent. In other words, the market is valuing a restructured listed shell that has been redeployed around a new strategic asset base. ([path2hydrogen.com](https://path2hydrogen.com/wp-content/uploads/2025/10/PMC-2025-HY-Bericht.pdf)) GenH2 is the core operating asset. It is described by the company as a technology leader in liquid hydrogen infrastructure systems, with capabilities in hydrogen liquefaction, transfer and controlled storage, including its Zero-Loss Controlled Storage technology. Path2 Hydrogen emphasizes standardized equipment and midstream infrastructure buildout, targeting hard-to-decarbonize sectors such as data centers, fuel cell applications, aviation and industrial supply chains. From a competitive perspective, the company’s differentiation lies in a narrow but potentially valuable niche: enabling the handling of liquid hydrogen at scale, where storage losses, transport complexity and infrastructure constraints are major bottlenecks. ([path2hydrogen.com](https://path2hydrogen.com/about-us/)) Recent corporate developments have been material. In July 2025, the company announced that its shares were also tradable on Xetra. In October 2025, it announced an exclusive option agreement to acquire ProtonH2, aiming to combine low-carbon hydrogen production with GenH2’s midstream technology and build a more vertically integrated hydrogen ecosystem. In April 2026, Path2 Hydrogen and MP Industries announced a strategic partnership to develop integrated hydrogen projects across Europe. Taken together, these events suggest a company moving from a single-asset hydrogen technology profile toward a broader platform strategy, with Germany as the listed base and the U.S. as an important operating hub. ([path2hydrogen.com](https://path2hydrogen.com/philomaxcap-ag-philomaxcap-ag-shares-now-trading-on-xetra/?utm_source=openai))